COVID-19 and novel mRNA vaccines in pregnancy: an updated literature review.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34651406.
- Also identified by DOI 10.1111/1471-0528.16973 and PMC identifier 8652509.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The novel coronavirus, SARS-CoV-2, or COVID-19, has affected the world on a pandemic scale resulting in catastrophic outcomes and deaths. Currently, there is limited safety data specific to mRNA vaccine use in pregnant or lactating individuals and the potential risks to a pregnant individual and the fetus are unknown. We report an updated literature review of current information and evidence available to aid in the decision whether to vaccinate against COVID-19 currently being made by pregnant individuals and their healthcare providers so that they are able to make a well-informed recommendation and decision.
Medical subject headings
- COVID-19
- COVID-19 Vaccines
- Pregnancy Complications, Infectious
- Prenatal Care
- mRNA Vaccines